Legal & General Group PLC Ab Cellera Biologics Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$7.31 - $11.18 $2,046 - $3,130
-280 Reduced 1.02%
27,044 $203,000
Q4 2022

Feb 14, 2023
BUY
$9.48 - $14.52 $3,877 - $5,938
409 Added 1.52%
27,324 $276,000
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $16,817 - $25,007
1,828 Added 7.29%
26,915 $266,000
Q2 2022

Aug 22, 2022
BUY
$5.72 - $10.65 $143,497 - $267,176
25,087 New
25,087 $267,000

Others Institutions Holding ABCL

# of Institutions
155
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $807M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email